Depressed youth, suicidality and antidepressants

Mansfield, Peter R; Raven, Melissa K; Jureidini, Jon N

doi:10.5694/j.1326-5377.2005.tb07039.x

Topics

Mental disorders

Pharmaceutical preparations

Peter R Mansfield,* Melissa K Raven,^† Jon N Jureidini^‡

1 University of Adelaide, SA
2 Flinders University, Adelaide, SA
3 Department of Psychological Medicine Women's and Children's Hospital, Adelaide, SA.

Correspondence: peter.mansfield@adelaide.edu.au

Competing interests:

We are all office bearers in Healthy Skepticism, an international non-profit organisation whose main aim is to improve health by reducing harm from misleading drug promotion.

1. Rey JM, Dudley MJ. Depressed youth, suicidality and antidepressants. Med J Aust 2005; 182: 378-379. <eMJA full text> <MJA full text>
2. March JS, for the TADS Group. Authors of TADS study reply to letter raising concerns. BMJ 2005; 330: 730-731.
3. Jureidini JN, Doecke CJ, Mansfield PR, et al. Efficacy and safety of antidepressants for children and adolescents. BMJ 2004; 328: 879-883.
4. Jureidini J, Tonkin A, Mansfield PR. TADS study raises concerns. BMJ 2004; 329: 1343-1344.
5. Timimi S. Rethinking childhood depression. BMJ 2004; 329: 1394-1396.
6. Katz D, Mansfield P, Goodman R, et al. Psychological aspects of gifts from drug companies. JAMA 2003; 290: 2404-2405.

Online responses are no longer available. Please refer to our instructions for authors page for more information.